6-135285617-C-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001134831.2(AHI1):​c.*28G>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0751 in 1,602,404 control chromosomes in the GnomAD database, including 6,223 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.12 ( 1583 hom., cov: 32)
Exomes 𝑓: 0.071 ( 4640 hom. )

Consequence

AHI1
NM_001134831.2 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.575

Publications

8 publications found
Variant links:
Genes affected
AHI1 (HGNC:21575): (Abelson helper integration site 1) This gene is apparently required for both cerebellar and cortical development in humans. This gene mutations cause specific forms of Joubert syndrome-related disorders. Joubert syndrome (JS) is a recessively inherited developmental brain disorder with several identified causative chromosomal loci. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Oct 2008]
AHI1 Gene-Disease associations (from GenCC):
  • Joubert syndrome 3
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen, Laboratory for Molecular Medicine, Ambry Genetics
  • Joubert syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Joubert syndrome with ocular defect
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • retinitis pigmentosa
    Inheritance: AR, AD Classification: SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 6-135285617-C-G is Benign according to our data. Variant chr6-135285617-C-G is described in ClinVar as Benign. ClinVar VariationId is 260835.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.246 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AHI1NM_001134831.2 linkc.*28G>C 3_prime_UTR_variant Exon 29 of 29 ENST00000265602.11 NP_001128303.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AHI1ENST00000265602.11 linkc.*28G>C 3_prime_UTR_variant Exon 29 of 29 1 NM_001134831.2 ENSP00000265602.6

Frequencies

GnomAD3 genomes
AF:
0.116
AC:
17652
AN:
152076
Hom.:
1572
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.250
Gnomad AMI
AF:
0.0396
Gnomad AMR
AF:
0.0844
Gnomad ASJ
AF:
0.0245
Gnomad EAS
AF:
0.0673
Gnomad SAS
AF:
0.108
Gnomad FIN
AF:
0.0243
Gnomad MID
AF:
0.0886
Gnomad NFE
AF:
0.0666
Gnomad OTH
AF:
0.104
GnomAD2 exomes
AF:
0.0730
AC:
17639
AN:
241654
AF XY:
0.0711
show subpopulations
Gnomad AFR exome
AF:
0.242
Gnomad AMR exome
AF:
0.0688
Gnomad ASJ exome
AF:
0.0268
Gnomad EAS exome
AF:
0.0610
Gnomad FIN exome
AF:
0.0250
Gnomad NFE exome
AF:
0.0614
Gnomad OTH exome
AF:
0.0622
GnomAD4 exome
AF:
0.0708
AC:
102717
AN:
1450210
Hom.:
4640
Cov.:
29
AF XY:
0.0707
AC XY:
51028
AN XY:
721362
show subpopulations
African (AFR)
AF:
0.257
AC:
8475
AN:
32982
American (AMR)
AF:
0.0715
AC:
3154
AN:
44112
Ashkenazi Jewish (ASJ)
AF:
0.0286
AC:
744
AN:
26034
East Asian (EAS)
AF:
0.0807
AC:
3187
AN:
39508
South Asian (SAS)
AF:
0.0986
AC:
8397
AN:
85164
European-Finnish (FIN)
AF:
0.0281
AC:
1478
AN:
52542
Middle Eastern (MID)
AF:
0.0659
AC:
378
AN:
5736
European-Non Finnish (NFE)
AF:
0.0654
AC:
72261
AN:
1104202
Other (OTH)
AF:
0.0775
AC:
4643
AN:
59930
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.427
Heterozygous variant carriers
0
4299
8599
12898
17198
21497
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2804
5608
8412
11216
14020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.116
AC:
17703
AN:
152194
Hom.:
1583
Cov.:
32
AF XY:
0.112
AC XY:
8331
AN XY:
74422
show subpopulations
African (AFR)
AF:
0.250
AC:
10375
AN:
41496
American (AMR)
AF:
0.0841
AC:
1286
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.0245
AC:
85
AN:
3470
East Asian (EAS)
AF:
0.0673
AC:
349
AN:
5186
South Asian (SAS)
AF:
0.108
AC:
519
AN:
4826
European-Finnish (FIN)
AF:
0.0243
AC:
258
AN:
10610
Middle Eastern (MID)
AF:
0.102
AC:
30
AN:
294
European-Non Finnish (NFE)
AF:
0.0666
AC:
4532
AN:
68006
Other (OTH)
AF:
0.110
AC:
233
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
756
1513
2269
3026
3782
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
180
360
540
720
900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0385
Hom.:
43
Bravo
AF:
0.125

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Joubert syndrome 3 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
Jun 16, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
6.8
DANN
Benign
0.59
PhyloP100
0.57
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9494209; hg19: chr6-135606755; COSMIC: COSV55624645; API